|
2011 Nucleosides, Nucleotides, and Oligonucleotides GRC
|
1R13CA159443-01
|
$3,500
|
PARKER, WILLIAM
|
GORDON RESEARCH CONFERENCES
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
1K08CA160660-01
|
$156,330
|
Kentsis, Alex
|
DANA-FARBER CANCER INSTITUTE
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-03
|
$291,849
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
Adenovirus-host interactions and in vivo virus targeting
|
5R01CA141439-03
|
$494,102
|
SHAYAKHMETOV, DMITRY
|
UNIVERSITY OF WASHINGTON
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,298,263
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-05
|
$283,822
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-03
|
$381,617
|
Brentjens, Renier
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$58,058
|
Kochenderfer, James
|
CCR (NCI)
|
|
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers
|
5R01CA152005-02
|
$295,874
|
Mohapatra, Shyam
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
5R01CA114340-05
|
$245,614
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antibody Neutralization of Therapeutic Viruses
|
5R01CA129966-04
|
$490,836
|
RUSSELL, STEPHEN
|
MAYO CLINIC
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
5K01CA138559-03
|
$142,677
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers
|
5R01CA138503-03
|
$301,913
|
Giangrande, Paloma
|
UNIVERSITY OF IOWA
|
|
Aspects of MUC13 Mucin in Cancer
|
5R01CA142736-02
|
$306,622
|
Chauhan, Subhash
|
SANFORD RESEARCH/USD
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011413
|
$116,117
|
Kochenderfer, James
|
CCR (NCI)
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
5R01CA077429-12
|
$419,987
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
Biodegradable Polymers For DNA Vaccine Delivery
|
5R01CA129189-04
|
$1
|
WANG, CHUN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-10
|
$2,140,227
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Training - Experimental Therapy Models
|
5T32CA009363-28
|
$247,098
|
LAND, HARTMUT
|
UNIVERSITY OF ROCHESTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-13
|
$377,387
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Carolina Center of Cancer Nanotechnology Excellence
|
5U54CA151652-02
|
$2,508,693
|
DeSimone, Joseph
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cell Prep Core
|
ZIC BC 010905
|
$885,718
|
Wunderlich, John
|
CCR (NCI)
|
|
Cell Production Facility Core
|
ZIC BC 011020
|
$885,718
|
Dudley, Mark
|
CCR (NCI)
|
|
Cellular co-factors in stable retroviral transduction
|
5R01CA125272-05
|
$228,532
|
DANIEL, RENE
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cellular Transduction with Replication-Competent Retrovirus Vectors
|
5R01CA121258-05
|
$476,828
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Center for Molecular Imaging Research at MGH/HMS
|
2P50CA086355-12
|
$1,521,775
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Center for Translational Cancer Nanomedicine
|
5U54CA151881-02
|
$2,558,928
|
TORCHILIN, VLADIMIR
|
NORTHEASTERN UNIVERSITY
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
3P01CA081534-11S2
|
$750,000
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-06A1
|
$2,185,000
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-03
|
$1,902,504
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$386,737
|
Feldman, Steven
|
CCR (NCI)
|
|
Clinical Scholars Biomedical Research Training Program
|
5T32CA009512-25
|
$267,676
|
KELLY, THOMAS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Combination Gene Therapy and Th1/Th2 Therapy
|
ZIA BC 011219
|
$218,895
|
Fowler, Daniel
|
CCR (NCI)
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-02
|
$413,032
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Conditionally Replicative Adenoviral Vectors for Malignant Glioma
|
5R01CA122930-04
|
$302,856
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
|
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
|
1P20CA151129-01A1
|
$700,000
|
GILLESPIE, G
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Converting an Oncogene to an Apoptotic Factor by Manipulating Signal Sequences
|
5R01CA129528-04
|
$275,147
|
LIM, CAROL
|
UNIVERSITY OF UTAH
|
|
CpG-siRNA Conjugates to Target Acute Myeloid Leukemia
|
1R01CA155367-01A1
|
$348,600
|
KORTYLEWSKI, MARCIN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cytokine modulated model growth inhibitory mechanisms
|
5R01CA105005-08
|
$261,603
|
KALVAKOLANU, DHAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth
|
ZIA BC 009264
|
$237,012
|
Ruscetti, Francis
|
CCR (NCI)
|
|
Designing Lymph Nodes for Cancer Immunotherapy
|
5R01CA148995-02
|
$336,129
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Detection and Analysis of Mouse Retroviruses in Humans
|
ZIA BC 011318
|
$188,480
|
Maldarelli, Frank
|
CCR (NCI)
|
|
Determining the mechanistic and therapeutic roles of microRNAs in bladder cancer
|
5R01CA138794-02
|
$260,852
|
Liang, Gangning
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Development and evaluation of apoptosis targeted therapies in lung cancer
|
ZIA BC 011049
|
$262,873
|
Kwong, King
|
CCR (NCI)
|
|
Development of Highly Targeted, Imageable Adenoviral Vectors for Prostate Cancer
|
5R01CA121153-05
|
$302,252
|
RODRIGUEZ, RONALD
|
JOHNS HOPKINS UNIVERSITY
|
|
Developmental Transcription Factors in Prostate Cancer
|
3R01CA106826-07S1
|
$84,196
|
MORENO, CARLOS
|
EMORY UNIVERSITY
|
|
Developmental Transcription Factors in Prostate Cancer
|
5R01CA106826-07
|
$300,175
|
MORENO, CARLOS
|
EMORY UNIVERSITY
|
|
Directed Protein Evolution for Design of LAGLIDADGs with Novel Recognition Speci
|
5RL1CA133832-05
|
|
SCHARENBERG, ANDREW
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Dissecting Glioma Genesis through a Glial-Specific Mouse Model
|
5R01CA098503-06
|
$252,836
|
Zhang, Wei
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
DNA Replication Control and Its Application to Selective Killing of Cancer Cells
|
5R00CA136555-03
|
$241,529
|
Zhu, Wenge
|
GEORGE WASHINGTON UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|